Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft Dysfunction. [PDF]
ABSTRACT Introduction Levosimendan, a calcium‐sensitizing inotropic agent, is used in patients with advanced heart failure (HF) awaiting heart transplantation (HT). Its prolonged effects, due to an active metabolite, may influence post‐transplant vasodilation, particularly when administered shortly before HT.
Guzman-Bofarull J +9 more
europepmc +4 more sources
Venoarterial Extracorporeal Life Support in Circulatory Shock Secondary to Severe Vasoplegia from Ramipril Overdose [PDF]
Management of angiotensin-converting enzyme inhibitors (ACEIs) overdose is historically challenging. We present the case of an overdose which was successfully managed with the utilization of venoarterial extracorporeal life support.
Johan van Nispen +5 more
doaj +3 more sources
Endothelial Damage in Sepsis: The Interplay of Coagulopathy, Capillary Leak, and Vasoplegia—A Physiopathological Study [PDF]
Background: Sepsis remains a leading cause of mortality worldwide, and understanding endothelial damage is crucial for improving patient outcomes. Endothelial dysfunction in sepsis contributes to coagulopathy, increased capillary permeability, and ...
Gianni Turcato +9 more
doaj +4 more sources
Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors [PDF]
Background Vasoplegia after routine cardiac surgery is associated with severe postoperative complications and increased mortality. It is also prevalent in patients undergoing implantation of pulsatile flow left ventricular assist devices (LVAD). However,
Eric E. C. de Waal +6 more
doaj +2 more sources
Successful use of methylene blue for severe vasoplegia in a patient with partially-treated portopulmonary hypertension with atrial septal defect undergoing liver transplantation: a case report [PDF]
Background Vasoplegia is a life-threatening intraoperative condition. Methylene blue (MB), a potent inhibitor of nitric oxide (NO) synthase and soluble guanylyl cyclase (sGC), can treat vasoplegia but may antagonize pulmonary arterial hypertension (PAH ...
Taiga Ishihara +5 more
doaj +2 more sources
Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment [PDF]
Prolonged postoperative vasoplegia is known to occur following cardiac surgery in patients on chronic angiotensin II receptor blocker (ARB) treatment in adults. The perioperative management of these drugs in the pediatric population is not well described
Nischal R. Pandya +10 more
doaj +2 more sources
Vitamin B12 (hydroxocobalamin) administration in the management of persistent vasoplegic shock [PDF]
Vasoplegia, characterized by low systemic vascular resistance despite normal to high cardiac output, can result from various conditions, including cardiac surgery, and progress to vasoplegic shock if untreated.
Jibran Ikram +4 more
doaj +2 more sources
Ascorbic acid and microcirculation in cardiothoracic surgery: a pilot feasibility trial and matched cohort study [PDF]
Background Ascorbic acid is an essential cofactor of catecholamine synthesis that increases capillary bed density and improves microcirculation perfusion.
Patrick M. Wieruszewski +6 more
doaj +2 more sources
Heart Failure Impacts Endothelial Cell Responses to Cardiac Surgery on Cardiopulmonary Bypass [PDF]
Patients with heart failure with a reduced ejection fraction (HFrEF) are at an increased risk of developing postoperative hemodynamic instability and vasoplegia after surgery on cardiopulmonary bypass (CPB). Potentially pre-existing endothelial cell (EC)
Olga Papazisi +11 more
doaj +2 more sources
Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series [PDF]
Background: The use of hydroxocobalamin following lung transplantation has not been previously reported. We present a series of 3 cases where hydroxocobalamin was used to treat postoperative vasoplegia.
Anh Nguyen, MD, PhD +10 more
doaj +2 more sources

